Skip to content
HeyJared

Christopher Lieu

Reporter · US

Indexed articles, last 90 days
1
Latest publication
Aug 26, 2026
Outlet visibility, for Southernminn.com
Top 500K sites
Earliest in this view
Aug 26, 2026
The latest indexed work is over 30 days old. There may be a gap in what we hold.

Latest articles

  1. Article · Aug 26, 2026 · Christopher Lieu, University of Colorado Anschutz

    FDA approves breakthrough pancreatic cancer drug – an oncologist explains how daraxonrasib nearly doubles survival (opens the original)

    Excerpt · English

    Read excerpt

    (AURORA, COLORADO) For a long time, the likelihood of surviving pancreatic cancer has been extremely low. For patients who were diagnosed with metastatic pancreatic cancer between 2015 and 2021, about 97% died within five years of their diagnosis. Pancreatic cancer is so deadly in part because there are no effective screening tests, and it rarely causes noticeable symptoms in its earliest stages. By the time a patient experiences signs, such as jaundice – a yellowing of the skin – or abdomin

Publishing over time

Last 90 days. Choose a month to open its work.

Recurring subjects

Named in the text we hold. One piece can cover several.

Audience

Top 500K sites

For Southernminn.com, the outlet · Measured Aug 1, 2026

Website popularity band, not a count of readers or article views.

About this data

Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.

Identity or attribution wrong? Suggest a correction.

See coverage about Christopher Lieu